Bowel (colorectal) cancer, Rectal cancer
Results
Phase 1
This trial looked at having enadenotucirev with chemoradiotherapy for people with cancer of the back passage (rectal cancer) that was locally advanced.
Enadenotucirev is a virus treatment for cancer. You pronounce enadenotucirev as en-ad-in-oh-too-sir-ev.
Locally advanced rectal cancer is cancer that has spread into the surrounding tissue.
Cancer Research UK supported this trial.
The trial was open for people to join between 2019 and 2022. The team presented the results at a conference in 2023.
Recruitment start: 1 July 2019
Recruitment end: 30 April 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Maria Hawkins
Cancer Research UK
Oncology Clinical Trials Office (OCTO)
PsiOxus Therapeutics Ltd
University of Oxford
This is Cancer Research UK trial number is CRUK/17/015.
Last reviewed: 15 Mar 2024
CRUK internal database number: 14956
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
